The FDA issued a notice in 2023 indicating BPC-157 cannot be compounded under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act because it does not appear on approved bulk substance lists
Huang P, Zhou Z, Huang R, Zhou B, Wei Q, Shi F
In some states, it is illegal to throw away medical sharps in household garbage, recycling, and compost bins
Translating a 50% reduction in healing time from rats to humans requires pharmacokinetic validation that doesn't exist
Phase 3 trials currently underway Seven TRIUMPH trials are testing retatrutide across multiple indications: TRIUMPH-1 : Obesity without diabetes TRIUMPH-2 : Type 2 diabetes TRIUMPH-3 : Obesity with type 2 diabetes TRIUMPH-4 : Obesity with knee osteoarthritis (COMPLETED, 28.7% weight loss) TRIUMPH-5 : Obstructive sleep apnea TRIUMPH-6 and 7 : Additional indications These trials will provide the definitive data for the commercial dosage chart
"Armoured Recovery Vehicles"